Summary by Moomoo AI
PHARMA MING BIOTECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON MAY 31, 2024 DISCLOSING SHARE REPURCHASES FOR THE PERIOD FROM DECEMBER 7, 2023 TO MAY 31, 2024. The company has made several share repurchases during this period, but has not written them off. The last repurchase took place on 31 May 2024. The number of shares repurchased on that date was 4,380,000 shares, priced between HKD 11.14 and HKD 11.66 for a total payment of HKD 49,724,740. Since the adoption of the Ordinary Resolution, the total number of securities repurchased by the Company on the Hong Kong Stock Exchange has reached 109,868,000 shares, representing 2.5861% of the issued shares. According to the report, all repurchases comply with the listing rules on the main board of the HKEx.